Send a Tweet
Most Popular Choices
Share on Facebook 8 Share on Twitter Printer Friendly Page More Sharing
General News    H4'ed 3/3/10

Cold Case Files - Paxil Birth Defects

By       (Page 14 of 19 pages) Become a premium member to see this article and all articles as one long page. (View How Many People Read This)   No comments
Author 38068
Message Evelyn Pringle

This report was never submitted to the FDA according to the testimony of Glaxo employees, Parisian said, but it should have been because it "is safety information."


In 1998, Glaxo prepared another internal report titled, "Paroxetine and Reports of Congential Abnormalities," with a cutoff date of November 1997, that showed 42 cases of congenital anomalies.


Parisian said this analysis was also never submitted to the FDA, as far as she knew, but under the rules it should have been.


Peavy then had Parisian review the draft version of the report, showing the same cutoff date and 42 congenital anomalies. On page 5, it stated: "The incidence rate of congenital abnormalities as observed in the data reported in this document is 13.3 percent."


But the draft version contained the following statements that did not appear in the final report: "A figure much higher than that reported by birth-defect monitoring bodies. Taken at face value, this represents an alarming finding."


Under FDA rules, drug companies are required to report alarming findings to the FDA, Parisian said. "They are also required to report any kind of safety analysis that they have done internally like this to address an issue about safety."


In fact, Peavy produced a 1984 letter to the company from the FDA, which specifically stated that the agency wanted to be informed about any "alarming findings" in either human or animal studies.


The 13.3 percent incident rate of congenital abnormalities was between six and seven times the 2.5 percent overall birth defect rate you would expect to see for births in the US, Parisian told the jury. The CDC uses a 2.5 percent background rate.


Next Page  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19

 

Rate It | View Ratings

Evelyn Pringle Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Evelyn Pringle is an investigative journalist and researcher focused on exposing corruption in government and corporate America.
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Tracking the American Epidemic of Mental Illness - Part II

Tracking the American Epidemic of Mental Illness - Part I

The Rise and Fall of Provigil -" Part I

The Rise and Fall of Provigil - Part II

Psychiatric Drugging of Infants and Toddlers in the US - Part I

Tracking the American Epidemic of Mental Illness - Part III

To View Comments or Join the Conversation: